PKG Health, today announced that it is presenting at DigiMed Showcase, part of Biotech Showcase™, on January 8, 2024 at 10:15am PT. CEO Zach Henderson will share an update on the rapid growth of the neurology market which combined with a severe shortage of neurologists globally results in a poor standard of care where less than 10% of patients with movement disorders are able to see a specialist. Thus, there exists a large, unmet market need for an AI/ML 'digital assist' to bridge the gap.
"For the rare few patients able to see a movement disorder specialist, there is only enough HCP capacity for 1-2 visits per year. And in that 20 minute visit, the patient is expected to recount everything that has happened for the last 6-12 months. An impossible ask. With PKG, physicians in over 20 countries are now leveraging our system to tailor treatment decisions similar to how CGMs provide actionable data to adjust insulin usage in the diabetes world."
The PKG® system provides a continuous, objective assessment of movement disorder symptoms, such as tremor, dyskinesia and bradykinesia during activities of daily living and in the patient’s home environment. Our industry leading, clinically validated FDA Class II cleared algorithms power precision medicine for patients, clinicians and our life science partners.
DigiMed Showcase is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.
“We are delighted that Zach will be joining us in San Francisco and presenting at DigiMed Showcase this year,” said Sara Demy, CEO of Demy-Colton. “DigiMed Showcase is a prime occasion for digital health leaders and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”
ABOUT DIGIMED SHOWCASE
DigiMed Showcase is part of Biotech Showcase, an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to meet with investors and pharmaceutical executives in one place. Investors and healthcare executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 16th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.
ABOUT PKG HEALTH
PKG Health leverages the world’s largest body of clinical evidence in neurology, to create and deliver precision medicine by accelerating the research, approval and adoption of treatments. Because we believe every person with a neurological condition deserves to live their best life every day. For more information on PKG Health, please visit us at www.pkghealth.com.
